Ask Google

Results for facit translation from English to Icelandic

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

English

Icelandic

Info

English

Mean change in FACIT‐T

Icelandic

Meðalbreyting á FACIT-T

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

FACIT-Fatigue (effect size)

Icelandic

FACIT-þreyta (virknistærð)

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

FACIT-Fatigue score at baseline (median)

Icelandic

FACIT-þreyta, stig í upphafi (miðgildi)

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

Improvements in FACIT scores were maintained through week 52.

Icelandic

Breyting til batnaðar með tilliti til FACIT stiga hélst út viku 52.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

FACIT-Fatigue score at last available assessment (median)

Icelandic

FACIT-þreyta, stig við síðasta fyrirliggjandi mat (miðgildi)

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

FACIT-Fatigue is measured on a scale of 0-52, with higher values indicating less fatigue

Icelandic

FACIT-þreyta er metin á kvarðanum 0–52 þar sem hærri gildi merkja minni þreytu

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

Benlysta demonstrated improvement in fatigue compared with placebo measured by the FACIT-Fatigue scale in the pooled analysis.

Icelandic

Hjá hópnum sem fékk Benlysta dró úr þreytu samanborið við lyfleysu, mælt með FACIT-þreytukvarða í safngreiningunni.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

Among patients who remained on the apremilast treatment, to which they were initially randomized at study start, improvement in physical function and FACIT- fatigue was maintained through Week 52.

Icelandic

Hjá sjúklingum sem voru áfram á þeirri apremilast meðferð sem þeir fengu skv. slembiröðun í upphafi rannsóknar voru þessar framfarir m.t.t. líkamlegrar færni og FACIT-þreytu enn til staðar í viku 52.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

Table 4: Efficacy Outcomes (LDH level and FACIT-Fatigue) in Patients with PNH with No History of Transfusion in M07-001

Icelandic

Tafla 4: Niðurstöður verkunar (LDH-gildi og FACIT-þreyta) hjá sjúklingum með PNH og enga sögu um blóðgjöf í M07-001

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

The proportion of patients achieving a clinically significant improvement in fatigue (4 points in FACIT-F) was also significantly greater in the ustekinumab groups compared with placebo.

Icelandic

Hlutfall sjúklinga sem náði klínískt marktækri breytingu til batnaðar með tilliti til þreytu (4 stig á FACIT-F) var einnig marktækt stærra í hópunum sem fengu ustekinumab, samanborið við lyfleysu.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

A statistically significant decrease in fatigue as measured by functional assessment of chronic illness therapy (FACIT) scores was seen in all three studies in which it was assessed (RA studies I, III, IV).

Icelandic

Tölfræðilega marktækt minni þreyta, mæld með FACIT-skori (functional assessment of chronic illness therapy), kom fram í þeim þremur rannsóknum þar sem þetta var metið (RA rannsóknir I, III og IV).

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

Furthermore, 74% of the patients treated with Soliris experienced clinically meaningful improvements in FACIT-Fatigue score (i.e., increase by 4 points or more) and 84% in EORTC fatigue score (i.e., decrease by 10 points or more).

Icelandic

Enn fremur fundu 74% sjúklinganna sem fengu Soliris fyrir bata með klíníska þýðingu á FACIT- þreytukvarðanum (þ.e. stigaaukning um 4 stig eða meira) og 84% á EORTC-þreytukvarðanum (þ.e. lækkun um 10 stig eða meira).

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

In GO-FORWARD and GO-AFTER, statistically significant improvements were observed in fatigue as measured by functional assessment of chronic illness therapy-fatigue scale (FACIT-F).

Icelandic

Í GO-FORWARD og GO-AFTER var tölfræðilega marktækt minni þreyta mæld með FACIT-F skala (functional assessment of chronic illness therapy).

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

In PsA Study 2 there was a significant improvement in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scores in the ustekinumab groups when compared with placebo at week 24.

Icelandic

Í rannsókn 2 á psoriasis liðagigt varð marktæk breyting til batnaðar hjá hópunum sem fengu ustekinumab, samkvæmt skori á mælikvarða á þreytu hjá fólki á meðferð við langvinnum sjúkdómum (Chronic Illness Therapy - Fatigue (FACIT-F)), samanborið við lyfleysu í 24 viku.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

In studies PALACE 1, PALACE 2 and PALACE 3, significant improvements were demonstrated in health- related quality of life, as measured by the changes from baseline in the physical functioning (PF) domain of the Short Form Health Survey version 2 (SF-36v2), and in the Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT-fatigue) scores in patients treated with apremilast compared to placebo at Weeks 16 and 24.

Icelandic

Í rannsóknum PALACE 1, PALACE 2 og PALACE 3 var sýnt fram á marktækar framfarir m.t.t. heilsutengdra lífsgæða, eins og þau eru mæld skv. breytingum frá upphafsgildum á þeim hluta könnunar á heilsufari sem metur líkamlega færni (e.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

Patients treated with Cosentyx 150 mg also showed statistically significant improvements on exploratory endpoints in physical function as assessed by the Bath Ankylosing Spondylitis Functional Index (BASFI) compared to placebo (-2.15 versus -0.68), and in fatigue as assessed by the Functional Assessment of Chronic Illness Therapy- Fatigue (FACIT-Fatigue) scale compared to placebo (8.10 versus 3.30).

Icelandic

Sjúklingar á meðferð með Cosentyx 150 mg sýndu einnig tölfræðilega marktæka bætingu hvað varðar könnunarendapunkta á líkamlegri færni samkvæmt BASFI (Bath Ankylosing Spondylitis Functional Index) samanborið við lyfleysu (-2,15 samanborið við -0,68), og á þreytu samkvæmt FACIT-Fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue) kvarðanum samanborið við lyfleysu (8,10 samanborið við 3,30).

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

Significant reductions in disability index (HAQ-DI) and fatigue (FACIT-Fatigue) scores were observed in patients treated with MabThera compared to patients treated with methotrexate alone.

Icelandic

Vart varð við marktæka lækkun á fötlunarstuðli (HAQ-DI) og þreytuskori (FACIT-Fatigue) hjá sjúklingum sem fengu MabThera samanborið við sjúklinga sem fengu metótrexat eitt sér.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

Significant reductions in disability index (HAQ-DI) and fatigue (FACIT-Fatigue) were observed in patients treated with MabThera compared to patients treated with methotrexate alone.

Icelandic

Vart varð við marktæka lækkun á fötlunarstuðli (HAQ-DI) og þreytuskori (FACIT-Fatigue) hjá sjúklingum sem fengu MabThera samanborið við sjúklinga sem fengu metótrexat eitt sér.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

English

There were also statistically significant improvements demonstrated in exploratory endpoints assessed by the Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT-F) scores for 150 mg and 300 mg compared to placebo (7.97, 5.97 versus 1.63, respectively).

Icelandic

Einnig varð tölfræðilega marktæk bæting sem kom fram í könnunarendapunktum samkvæmt FACIT-F (Functional Assessment of Chronic Illness Therapy – Fatigue) skori fyrir 150 mg og 300 mg samanborið við lyfleysu (7,97, 5,97 samanborið við 1,63 í þessari röð).

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Get a better translation with
4,401,923,520 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK